Abstract

We report a detailed study of a cohort of sporadic Creutzfeldt-Jakob disease (sCJD) VV1–2 type-mixed cases (valine homozygosity at codon 129 of the prion protein, PrP, gene harboring disease-related PrP, PrPD, types 1 and 2). Overall, sCJDVV1–2 subjects showed mixed clinical and histopathological features, which often correlated with the relative amounts of the corresponding PrPD type. However, type-specific phenotypic characteristics were only detected when the amount of the corresponding PrPD type exceeded 20–25%. Overall, original features of types 1 (T1) and 2 (T2) in sCJDVV1 and -VV2, including rostrocaudal relative distribution and conformational indicators, were maintained in sCJDVV1–2 except for one of the two components of T1 identified by electrophoretic mobility as T121. The T121 conformational characteristics shifted in the presence of T2, inferring a conformational effect of PrPD T2 on T121. The prevalence of sCJDVV1–2 was 23% or 57% of all sCJDVV cases, depending on whether standard or highly sensitive type-detecting procedures were adopted. This study, together with previous data from sCJDMM1–2 (methionine homozygosity at PrP gene codon 129) establishes the type-mixed sCJD variants as an important component of sCJD, which cannot be identified with current non-tissue based diagnostic tests of prion disease.

Details

Title
Co-existence of PrPD types 1 and 2 in sporadic Creutzfeldt-Jakob disease of the VV subgroup: phenotypic and prion protein characteristics
Author
Cali Ignazio 1 ; Puoti Gianfranco 2 ; Smucny, Jason 3 ; Curtiss, Paul Michael 4 ; Cracco, Laura 5 ; Kitamoto Tetsuyuki 6 ; Occhipinti Rossana 7 ; Cohen, Mark Lloyd 1 ; Appleby, Brian Stephen 8 ; Gambetti Pierluigi 5 

 Case Western Reserve University, School of Medicine, Department of Pathology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, National Prion Disease Pathology Surveillance Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
 University of Campania “L. Vanvitelli”, Department of Advanced Medical and Surgical Sciences, Caserta, Italy (GRID:grid.67105.35) 
 University of California, Department of Psychiatry, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684) 
 New York University, School of Medicine, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753) 
 Case Western Reserve University, School of Medicine, Department of Pathology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
 Tohoku University Graduate School of Medicine, Department of Neurological Science, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 Case Western Reserve University, School of Medicine, Department of Physiology and Biophysics, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
 Case Western Reserve University, School of Medicine, Department of Neurology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, Department of Psychiatry, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, National Prion Disease Pathology Surveillance Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2348776987
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.